BENYLIN DRY COUGH

This brand name is authorized in Nigeria.

Active ingredients

The drug BENYLIN DRY COUGH contains one active pharmaceutical ingredient (API):

1	Demorphan UNII 9D2RTI9KYH - DEXTROMETHORPHAN HYDROBROMIDE
	Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors.
	Read more about Demorphan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7111	Syrup	Benylin Dry Cough Syrup SYRUP 15 mg/5 mL 100ml,200ml	Benylin Dry Cough Syrup DEXTROMETHORPHAN 15mg/5ml DEXTROMETHORPHAN 15mg/5ml, Sodium Benzoate 0.5%m/v, Sugar Free, Alcohol Free, Sorbitol, Glycerine. B4-7111 Drugs Imported Products 100ml,200ml Over The Counter (OTC) 23/03/2022 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 DL-CONZACTCTRegulatoryAffairs@JNJZA.JNJ.com Johnson & Johnson (PTY) Ltd, 241, Main Road, Retreat, Cape Town, 7945, South Africa, South Africa	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R05DA09	Dextromethorphan	R Respiratory system → R05 Cough and cold preparations → R05D Cough suppressants, excl. combinations with expectorants → R05DA Opium alkaloids and derivatives
Discover more medicines within R05DA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7111